摘要
目的研究硬性透氧性角膜接触镜(RGP)对单眼屈光参差性弱视儿童矫治效果。方法选取2014年2月至2015年8月西安市中心医院收治的单眼屈光参差性弱视患儿110例。根据治疗方式的不同分为观察组59例,对照组51例。观察组予以RGP矫正视力,对照组则佩戴框架眼镜矫正视力。分别对两组患儿进行为期1年的随访,比较视力矫正情况,临床疗效,并发症发生情况以及患儿满意度。结果观察组配镜后1个月、6个月及12个月后矫正视力分别为(4.33±0.31)、(4.52±0.47)、(4.76±0.29),均高于对照组的(4.19±0.30)、(4.33±0.40)、(4.41±0.44),差异有统计学意义(均P<0.05)。观察组治疗总有效率为67.80%(40/59),高于对照组的43.14%(22/51),差异有统计学意义(P<0.05)。两组并发症发生率对比不明显,差异无统计学意义(P>0.05)。观察组病人满意度为100.00%(59/59),高于对照组的90.20%(46/51),差异有统计学意义(P<0.05)。结论 RGP对单眼屈光参差性弱视患儿的矫治效果显著,且安全性较好,更容易为患儿所接受。
Objective To study the effect of rigid gas permeable contact lens(RGP)on the correction of monocular anisometropia amblyopic in children.Methods One hundred and ten cases with monocular anisometropia amblyopic from February 2014 to August 2015,in our hospital were selected and divided into observation group and control group according to the different methods of treatment.Observation group was treated with contig-oriented vision correction,while the control group wore glasses for vision correction.The children in the two groups were followed up for one year,and the visual acuity,clinical efficacy,complications and satisfaction of the children were compared.Results The observation group of the equipping mirror after 1 month,6 months and 12 months after the vision correction respectively was(4.33±0.31),(4.52±0.47),(4.76±0.29)were higher than in the control group(4.19±0.30),(4.33±0.40),(4.41±0.44),with significant difference(P<0.05).The observation group of total effective rate was 67.80%(40/59),higher than that of control group 43.14%(22/51),with significant difference(P<0.05).The complication rate of two groups of contrast was not obvious,with no significant difference(P>0.05).Observation group of patients′satisfaction was 100.00%(59/59),higher than that of control group 90.20%(46/51),with significant difference(P<0.05).Conclusion Correcting effect of RGP on monocular anisometropia amblyopic children is remarkable and with good security,more easily accepted by children.
作者
董玉红
霍敏
张静
DONG Yuhong;HUO Ming;ZHANG Jing(Department of Ophthalmology,Xi′an Central Hospital,Xi′an,Shaanxi 710061,China)
出处
《安徽医药》
CAS
2019年第3期510-512,共3页
Anhui Medical and Pharmaceutical Journal
